Skip to content
TrustList
Kingdon Capital logo
Venture capital firm

Kingdon Capital

New York alternative investment firm founded in 1983 and registered with the US securities regulator since 2012

Kingdon Capital cover

About Kingdon Capital

Kingdon Capital Management, LLC, also called Kingdon or the Firm, is an alternative investment firm with its headquarters in New York. Mark Kingdon started it in April 1983, so it has operated for several decades.

What Kingdon Capital offers

  • Alternative investing: the firm describes its business as alternative investment management.
  • Regulated status: it has been a registered investment adviser under the US Securities and Exchange Commission since March 2012.
  • New York base: the firm runs from a headquarters in that city.

Who it serves

The site gives no details on client types. It does carry a client login area, and it notes that SEC registration does not imply any level of competence or approval from the regulator.

Key facts

  • Based in: New York
  • Founded: 1983, by Mark Kingdon
  • Regulation: registered investment adviser with the SEC since March 2012

Profile written by TrustList from the business's own published information, Oct 2026.

What the business tells TrustList

Founded
1983 (43 years) evidence sent

Ask TrustList to introduce you to Kingdon Capital

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Kingdon Capital

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Kingdon Capital.

Kingdon Capital alternatives

Similar listings buyers compare against this one.

Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Life science investor putting money into young oncology and genetic disease drug developers

Venture capital firm supporting startups with risk capital, strategic advice and industry access